APEXASCENSION Request a private review

Private healthcare investor acquisition

Cut 5 months of fundraisingdown to 45 days.

We identify the funds, family offices and strategic investors actually capable of participating, then pursue every practical route in.

Real people.Real results.

Clients on the record

Healthcare operators. In their own words.

Michael J. Gardner, MD, Founder of National Scoliosis Clinic National Scoliosis Clinic

Seed Extension - Digital Health

“Raising funds was challenging, especially getting in front of investors. This time, we've partnered with Apex Ascension, and the results have been phenomenal.”
Michael J. Gardner, MDFounder, National Scoliosis Clinic
Starting point

Polite conversations. Zero escalation. Four months mistaking politeness for progress.

Apex execution

Investor behavior was measured, separating real alignment from polite interest.

Outcome

Aligned investors surfaced. First tranche closed with a top-tier fund.

Pattern observed across 50+ healthcare raises

Different companies. The same fundraising pattern repeats.

Before Apex

Months of meetings. Polite interest. Little escalation. Founder time spent pursuing investors who were never positioned to participate.

After Apex

Credible capital is prioritized, investor behavior becomes interpretable, and follow-up concentrates on the paths showing real forward motion.

When company readiness and investor alignment are present

Weeks 1–3

Aligned investor meetings begin.

Weeks 5–7

Diligence requests and deeper investor review.

Months 2–3

Term-sheet discussions and potential term sheets.

Selective by designWe work with only four healthcare companies per month.

Selected clients shown with permission. Additional references are available upon request.

The pattern and timing shown reflect selected Apex engagements across 50+ healthcare raises. Company readiness, investor alignment, timelines and capital outcomes vary. Apex is compensated on a fixed-fee basis that is not contingent on capital raised.

Hundreds of meetings.No term sheets.

Stalled rounds are rarely an activity problem. They are a coverage problem. Meeting after meeting gets booked with funds that were never able to participate, and every one of them still looks like progress on a calendar.

Wrong stageWrong check sizeNo current mandateFollower onlyGeography mismatchNot actively deploying
From a recent deployment, day 21 83 funds contacted. 9 showed forward action. 6 were structurally dead before outreach began.

The mandate

One investor market.Every practical route in.

Match

Define the funds, family offices and strategics genuinely capable of participating, by sub-sector, stage, check size, geography and capital role.

Pursue

Run coordinated outreach across email, phone, LinkedIn, warm paths and multiple decision-makers inside each priority investor account.

Advance

Manage replies, qualify interest, schedule management conversations and maintain follow-through across every viable relationship.

Investor meetings by week 3. Due diligence requests by week 5.

The right investorshould never dependon one inbox.

Apex treats each priority investor as an account, not an email address. Partner, principal, associate, executive assistant, an existing connection, a portfolio-company route. Multiple decision-makers. Multiple channels. One coordinated pursuit.

Email sequence, multi-contactWorking
Phone, direct and deskWorking
LinkedIn, partner and associateWorking
Warm introduction pathWorking
Founder-level escalationWorking
Qualified management conversationBooked

Already have a banker?Good.

Apex does not require you to replace an existing process. Your banker, board and current investors keep working their relationships. Apex identifies and pursues the right-fit portion of the market that remains uncovered.

Your existing process

  • Banker relationships
  • Existing investors
  • Board network
  • Warm introductions

Apex

  • Uncovered funds
  • Family offices
  • Strategic investors
  • Direct multichannel pursuit
Management conversations

Who we work with

Built for companies withsomething real to finance.

Apex fit

  • Private biotech, medtech, diagnostics or digital-health company
  • Active institutional raise
  • Meaningful clinical, regulatory or commercial validation
  • CEO or CFO directly involved
  • An existing investor process, banker or network that needs greater right-fit coverage
  • A defined financing timeline

Not a fit

  • Casually exploring whether to raise
  • No defined institutional financing process
  • Seeking commission-only placement
  • Looking only for a static investor list
  • Expecting Apex to negotiate or execute the securities transaction
Submit the company and round

A short, confidential mandate review.

Apex evaluates fit

We review the company, the financing profile and whether the investor market is suitable for Apex execution.

Selected companies enter a mandate discussion

The conversation focuses on the uncovered market, scope and the 45-day execution plan.

Request a private review

Select mandates. Every engagement begins with a private fit review.

Nam Tran, founder of Apex Ascension
Nam TranFounder

Founded by Nam Tran, Apex applies enterprise-grade healthcare go-to-market execution to private capital formation. Apex also operates Capitalmarketfit.com, a weekly capital briefing, followed by 3000+ healthcare leaders, that decodes how private capital flows in healthcare.

The right healthcare investors.Pursued properly.

Request a private review